Helping get new treatment options to patients, faster.
Experts in formulation development
Quotient Sciences' approach to formulation development is based on the physical, chemical, and biopharmaceutic properties of each peptide, and we build robust, fit-for-purpose early development programs that meet Investigational New Drug Application (IND) and other regulatory requirements.
- Peptide characterization and preformulation
- Biopharmaceutics profiling to guide route of delivery and formulation strategy
- Pre-clinical and clinical formulation development and optimization
- Phase I clinical assessment in healthy volunteers
Dosage forms for delivery routes
- Oral, including regional delivery
- Parenteral, including intravenous (IV), subcutaneous (SC), and intramuscular (IM)
- Inhaled
- Nasal
- Topical
- Rectal
- Vaginal
Clinical testing capabilities
- First-in-human (FIH) studies
- Relative bioavailability studies to optimize drug delivery technology performance
- Absolute bioavailability studies
- Bioanalysis
